Skip to content
Lower risk Drug recall · FDA · Published October 20, 2023

ITF Pharma Recalls Tiglutik Oral Suspension Due to Viscosity Issues

ITF Pharma recalls Tiglutik oral suspension (50 mg/10 mL) due to failed viscosity tests. This medication is prescription-only and may not mix properly, affecting dosing accuracy.

🇺🇸 FDA recall #D-0115-2024DrugITF Pharma ›
Take action

Contact the company

Recalling firmITF PHARMA INC850 Cassatt Rd · Berwyn, PA 19312-2701
✎ GovInfoNow plain-language explainer

ITF Pharma is recalling Tiglutik oral suspension because it failed viscosity tests. This means the suspension might not mix properly, leading to incorrect dosing for patients using it as prescribed. Read more at govinfonow.com/recall/33040-itf-pharma-recalls-tiglutik-oral-suspension-due-to-viscosity-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/33040-itf-pharma-recalls-tiglutik-oral-suspension-due-to-viscosity-issues · Updated September 23, 2026 · FDA enforcement record: FDA #D-0115-2024

Cite this page

“ITF Pharma Recalls Tiglutik Oral Suspension Due to Viscosity Issues.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33040-itf-pharma-recalls-tiglutik-oral-suspension-due-to-viscosity-issues. Based on FDA recall #D-0115-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0115-2024%22&limit=1).

ITF Pharma Inc. voluntarily recalled Tiglutik (riluzole) Oral Suspension due to failed viscosity specifications, the FDA said on Oct. 20, 2023. The Class II recall involves 1,792 bottles distributed to a Tennessee distributor.

How to tell if you have it

  • Brand: ITF Pharma
  • Product: Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL), 600 mL
  • NDC: 70726-0303-1 (carton) and 70726-0303-2 (bottle)
  • Lot codes: 2231901, Exp. 11/30/2025; 2307901, Exp. 03/31/2026

The hazard

The recall was initiated because the product failed viscosity specifications, resulting in out-of-specification test results. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show other recent recalls of similar products include Sun Pharmaceutical Fluocinonide Cream Recall (2026-03-25) and Sun Pharmaceutical Diclofenac Gel Recall (2026-01-27). Somerset Therapeutics Cisatracurium Besylate Injection Recall occurred on 2025-11-26.

How to tell if you have this one

Check for the product name 'Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL), 600 mL (two bottles/300 mL each)'. Look for lot numbers 2231901 (expiring 11/30/2025) or 2307901 (expiring 03/31/2026).

  • Brand
    ITF Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number and expiration date on the packaging to confirm if your product is affected.

Where it went and when

Where it was distributed

Distributed in Tennessee.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: yesTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Distributed to one distributor in TN who may have further distributed.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Tennessee.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: Oct 20, 202312. FDA classified it Class II: Nov 21, 202323. Published in FDA’s Enforcement Report: Nov 29, 202334. FDA terminated the recall: Jan 28, 2025420232025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this medication safe to use?

The recall is due to failed viscosity tests, which may affect dosing accuracy. It is not safe to use as intended without checking the recall status.

Is there a risk of serious injury?

The hazard is related to potential dosing errors, not direct injury. The risk level is low as the issue affects medication accuracy, not immediate safety.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0115-2024 (October 20, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0115-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA